secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001437749-22-027857
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs loses key customer Sema4; orders to drop starting Q3 FY2023
---------------------------------------------------------------------

- Sema4 exiting reproductive health screening; will significantly reduce consumables orders starting Q3 FY2023.
- Without Sema4, Clinical Genomics ex-COVID revenues would have been ~$56.3M vs $64.5M over prior 12 months.
- Sema4 products generated significantly higher gross profit percentage than overall Clinical Genomics business.
- Mesa has no other material revenues for expanded carrier screening with other customers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774922027857/0001437749-22-027857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774922027857/mlab20221121_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-027857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer